Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis
Authors
Keywords
-
Journal
Neurotherapeutics
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-03
DOI
10.1007/s13311-020-00921-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
- (2020) Anthony Traboulsee et al. LANCET NEUROLOGY
- Efficacy and safety of rituximab in autoimmune encephalitis: A meta‐analysis
- (2020) Gaurav Nepal et al. ACTA NEUROLOGICA SCANDINAVICA
- Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
- (2019) Fulin Gao et al. BMC Neurology
- Development of the clinical assessment scale in autoimmune encephalitis
- (2019) Jung-Ah Lim et al. ANNALS OF NEUROLOGY
- An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
- (2019) Josep Dalmau et al. LANCET NEUROLOGY
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
- (2019) Bruce A C Cree et al. LANCET
- Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
- (2019) Takashi Yamamura et al. NEW ENGLAND JOURNAL OF MEDICINE
- N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications
- (2018) Mateusz Makuch et al. ANNALS OF NEUROLOGY
- Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
- (2018) Divyanshu Dubey et al. ANNALS OF NEUROLOGY
- Antibody-Mediated Encephalitis
- (2018) Josep Dalmau et al. NEW ENGLAND JOURNAL OF MEDICINE
- High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
- (2018) Yoonhyuk Jang et al. Scientific Reports
- Tocilizumab treatment for new onset refractory status epilepticus
- (2018) Jin-Sun Jun et al. ANNALS OF NEUROLOGY
- A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis
- (2018) Ramani Balu et al. NEUROLOGY
- Treatment strategies for autoimmune encephalitis
- (2017) Yong-Won Shin et al. Therapeutic Advances in Neurological Disorders
- A clinical approach to diagnosis of autoimmune encephalitis
- (2016) Francesc Graus et al. LANCET NEUROLOGY
- Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort
- (2016) Woo-Jin Lee et al. NEUROLOGY
- Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
- (2016) Franziska Scheibe et al. NEUROLOGY
- Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
- (2016) Woo-Jin Lee et al. Neurotherapeutics
- Bortezomib Treatment for Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis
- (2016) Volker Behrendt et al. JAMA Neurology
- Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model
- (2015) Sukhvir Wright et al. BRAIN
- Clinical manifestations of patients with CASPR2 antibodies
- (2015) Jun-Sang Sunwoo et al. JOURNAL OF NEUROIMMUNOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- New-onset refractory status epilepticus
- (2015) Nicolas Gaspard et al. NEUROLOGY
- Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis
- (2014) Tae-Joon Kim et al. JOURNAL OF NEUROIMMUNOLOGY
- Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
- (2014) R. C. Dale et al. NEUROLOGY
- The Biology and Medical Implications of Interleukin-6
- (2014) T. Tanaka et al. Cancer Immunology Research
- Rituximab ameliorates anti-N-methyl-d-aspartate receptor encephalitis by removal of short-lived plasmablasts
- (2013) Yasuo Hachiya et al. JOURNAL OF NEUROIMMUNOLOGY
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
- (2013) Maarten J Titulaer et al. LANCET NEUROLOGY
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2012) Erwin W. Gelfand NEW ENGLAND JOURNAL OF MEDICINE
- Cognitive deficits following anti-NMDA receptor encephalitis
- (2011) Carsten Finke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
- (2010) Sarosh R. Irani et al. BRAIN
- Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma
- (2009) Erdem Tüzün et al. ACTA NEUROPATHOLOGICA
- Mature and immature ovarian teratomas: CT, US and MR imaging characteristics
- (2008) Luca Saba et al. EUROPEAN JOURNAL OF RADIOLOGY
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
- (2008) Josep Dalmau et al. LANCET NEUROLOGY
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005
- (2006) Peter J Barnes BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More